DAFTAR PUSTAKA

1. The Joint United Nations Programme on HIV/AIDS. Global AIDS statistic

2014. World Health Organization; 2015.
2. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan
Kementerian Kesehatan Republik Indonesia. Situasi dan analisis
HIV/AIDS. Pusat Data dan Informasi Kementerian Kesehatan Republik
Indonesia; 2014.
3. Fauci A, Lane HC. Human Immunodeficiency Virus Disease: AIDS and
Related Disorders. In : Longo D, Fauci A, Fauci A, Kasper D, Braunwald
E, Hause S, et al. Harrison’s Principles of Internal Medicine. 20th ed.
United States of America: McGraw-Hill; 2015.p.241-50.
4. Djoerban Z, Djauzi S. HIV/AIDS di Indonesia. In: Buku Ajar Ilmu
Penyakit Dalam Jilid III. 6th ed. Jakarta: Balai Penerbit FKUI; 2014. 1825–
1829.
5. Djauzi S, Djoerban Z. Penatalaksanaan Infeksi HIV di Pelayanan
Kesehatan Dasar. Edisi 2. Jakarta: Fakultas Kedokteran Universitas
Indonesia; 2003.
6. CDC. Guidelines for prevention and treatment of opportunistic infections
in hiv-infected adults and adolescents. Recommendations from CDC, the
National Institutes of Health and the HIV Medicine Association of the
Infectious Diseases Society of America. MMWR; 2009.58(RR04):1–198.
7. Koutsky LA, Kiviat NB. Genital Human Papillomavirus. In Holmes:
Sexually Transmitted Diseases. 3rd ed. New York: McGraw Hill; 2002.p
347 – 356.
8. Altman K, Vanness E, Westergaard RP. Cutaneous manifestations of
human immunodeficiency virus: a clinical update. Curr Infect Dis Rep.
2015; 17(3):464.
9. Anderson RM. Transmission Dynamics of Sexually Transmitted
Infections. In Holmes: Sexually Transmitted Diseases. 3rd ed. New York:
McGraw Hill; 2002. 25 - 37.

1
10. Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg
MA, et al. Primary care guidelines for the management of persons infected
with HIV: 2013 Update by the HIV Medicine Association of the Infectious
Diseases Society of America. Clin Infect Dis.2014; 58(1): 1–34.
11. Skiest DJ, Vazquez JA, Anstead GM, Graybill JR, Reynes J, Ward D, et
al. Posaconazole for the treatment of azolerefractory oropharyngeal and
esophageal candidiasis in subjects with HIV infection. Clin Infect Dis.
2007; 44(4): 607–614.
12. Bellavista S, Antuono DA, Infusiono DS, Trimarco R, Patrizi A. Pruritic
popular eruption in HIV: a case successfully treated with NB-UVB.
Dermatol Ther. 2013; 16: 173-5.
13. Berman B, Flores F, Burke G. Efficacy of pentoxifylline in the treatment
of pruritic papular eruption of HIV-infected persons. J Am Acad
Dermatol. 2011;38: 955-9.
14. Sandhu A, Samra AK. Opportunistic infections and disease implications in
HIV/AIDS. IJPSI. 2013; 2(5): 47-54.
15. Afonso JPJM, Tomimori J, Michalany NS, Nonogaki S, Porro AM.
Pruritic papular eruption and eosinophilic folliculitis associated with
human immunodeficiency virus (HIV) infection: A histopathological and
immunohistochemical comparative study. Journal of the American
Academy of Dermatology. 2012; 67(2): 269–75.